BEAM Dec 2024 29.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:30AM EDT. Market open.
| Previous close | 3.5000 |
| Open | 3.3400 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 29.00 |
| Expiry date | 2024-12-20 |
| Day's range | 3.3400 - 3.5000 |
| Contract range | N/A |
| Volume | |
| Open interest | 20 |
Simply Wall St.Beam Therapeutics Inc. (NASDAQ:BEAM) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Beam Therapeutics Inc. ( NASDAQ:BEAM ) shareholders are probably feeling a little disappointed, since its shares fell...
ZacksBeam Therapeutics (BEAM) Q1 Loss Narrows, Revenues Miss
Beam Therapeutics (BEAM) reports mixed first-quarter results. The company remains focused on pipeline development.
GlobeNewswireBeam Therapeutics to Participate in RBC Capital Markets 2024 Global Healthcare Conference
CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer of Beam, plans to participate in a fireside chat during the RBC Capital Markets 2024 Global Healthcare Conference on Wednesday, May 15, 2024, at 1:35 p.m. ET in New York City. A live webcast will be available in the investor section of the company's website at www.bea
© 2024 Yahoo. All rights reserved.